Literature DB >> 8717601

Measuring heart patients' willingness to pay for changes in angina symptoms.

L G Chestnut1, L R Keller, W E Lambert, R D Rowe.   

Abstract

Willingness-to-pay (WTP) measures of the effects of changes in health on a person's welfare are more comprehensive than traditional cost-of-illness (COI) measures, but they are sometimes difficult to obtain. The authors investigated two approaches for measuring heart patients' WTP for changes in their angina symptoms. First, actual expenditures and perceived angina episodes avoided were used to infer an averting-behavior measurement of WTP. Second, a contingent-valuation approach was used to ask direct WTP questions regarding a hypothetical medical treatment that could be purchased to avoid additional angina episodes. The results indicated that although negligible COI changes were expected with small changes in angina frequency, the subjects had significant WTP to avoid increases in angina. The average WTP to avoid additional angina episodes revealed by the averting-behavior questions was comparable to the directly-elicited WTP, providing a test of the validity of the contingent-valuation approach.

Entities:  

Mesh:

Year:  1996        PMID: 8717601     DOI: 10.1177/0272989X9601600115

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  14 in total

1.  Willingness to pay for mammography: item development and testing among five ethnic groups.

Authors:  T H Wagner; T W Hu; G V Dueñas; R J Pasick
Journal:  Health Policy       Date:  2000-09       Impact factor: 2.980

2.  Unexpected yes- and no-answering behaviour in the discrete choice approach to elicit willingness to pay: a methodological comparison with payment cards.

Authors:  Thomas Hammerschmidt; Hans-Peter Zeitler; Reiner Leidl
Journal:  Int J Health Care Finance Econ       Date:  2003-09

3.  Defining monetary values for quality of life improvements: an exploratory study.

Authors:  Jean Lachaine; Claudine Laurier; André-Pierre Contandriopoulos
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

4.  Exploring a new method for deriving the monetary value of a QALY.

Authors:  Carl Tilling; Marieke Krol; Arthur E Attema; Aki Tsuchiya; John Brazier; Job van Exel; Werner Brouwer
Journal:  Eur J Health Econ       Date:  2015-08-20

5.  Willingness-to-pay to prevent Alzheimer's disease: a contingent valuation approach.

Authors:  Rashmita Basu
Journal:  Int J Health Care Finance Econ       Date:  2013-08-31

6.  Urge incontinence. Quality of life and patients' valuation of symptom reduction.

Authors:  R M O'Conor; M Johannesson; S L Hass; G Kobelt-Nguyen
Journal:  Pharmacoeconomics       Date:  1998-11       Impact factor: 4.981

7.  Assessment of the relationship between measures of disease severity, quality of life, and willingness to pay in asthma.

Authors:  Alan J Zillich; Karen Blumenschein; Magnus Johannesson; Patricia Freeman
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

8.  Measuring preferences for schizophrenia outcomes with the time tradeoff method.

Authors:  Martha Shumway; Tandy L Chouljian; Cynthia L Battle
Journal:  J Behav Health Serv Res       Date:  2005 Jan-Mar       Impact factor: 1.505

9.  Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis.

Authors:  Patrick W Sullivan; Sheryl L Follin; Michael B Nichol
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  Averting Behavior Framework for Perceived Risk of Yersinia enterocolitica Infections.

Authors:  Sonia N Aziz; Khwaja M S Aziz
Journal:  J Pathog       Date:  2012-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.